Transgenic Group Inc. (TYO:2342)

Transgenic Group Revenue

Transgenic Group had revenue of 3.66B JPY in the quarter ending June 30, 2026, with 14.45% growth. This brings the company's total for the last twelve months to 13.64B, up 2.37% year-over-year. In the fiscal year ending March 31, 2026, Transgenic Group had annual revenue of 13.17B with 1.30% growth. That makes Transgenic Group the 23,745th largest company in the world by revenue and 2,554th in Japan.

• Revenue (ttm): 13.64B
• Revenue Growth: +2.37%
• P/S Ratio: 0.27
• Revenue / Employee: 60.07M
• Employees: 227
• Market Cap: 3.63B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Investment and Consulting Business 10.92B 82.9%
• Drug Discovery Support Business 2.26B 17.1%

Fiscal year ended Mar 31, 2026 See the full Transgenic Group breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	13.17B	169.00M	1.30%
Mar 31, 2025	13.01B	-78.00M	-0.60%
Mar 31, 2024	13.08B	1.65B	14.47%
Mar 31, 2023	11.43B	-1.15B	-9.12%
Mar 31, 2022	12.58B	1.53B	13.85%

Data Source: S&P Global Market Intelligence Last updated: Aug 12, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 23, 2026

Data Sources Report a data error